Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
HPV-Related Cervical Carcinoma: early-phase trial registry
2 of 5 indexed HPV-Related Cervical Carcinoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count
HPV-Related Cervical Carcinoma: 5 US clinical trials tracked, 2 recruiting.
HPV-Related Cervical Carcinoma is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Transgene, running 1 of these trials.
Enrollment posture brief
Registry condition hpv-related-cervical-carcinoma
OPEN 2 | RECR 40% | LATE 0 | EARLY 3 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
HPV-Related Cervical Carcinoma lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for HPV-Related Cervical Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
HPV-Related Cervical Carcinoma is recruiting below its size-band peers.
2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates HPV-Related Cervical Carcinoma research.
Transgene accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical HPV-Related Cervical Carcinoma enrolment sits around 143 participants.
Median target enrolment is 143 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
HPV-Related Cervical Carcinoma research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
Theravectys S.A.
NCT06319963
Detecting HPV DNA in Anal and Cervical Cancers
University of Chicago
NCT04857528
A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors
TScan Therapeutics
NCT05973487
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
Transgene
NCT03260023
Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake
University of Pennsylvania
NCT03337269
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on HPV-Related Cervical Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on HPV-Related Cervical Carcinoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this HPV-Related Cervical Carcinoma page
5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 HPV-Related Cervical Carcinoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Transgene sponsors the most HPV-Related Cervical Carcinoma trials on record, review their full trial history before evaluating a specific study. See Transgene's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This HPV-Related Cervical Carcinoma condition card totals 5 registered trials; most-linked intervention Educational handout; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.